Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Charlie Schmidt
New drugs approved for advanced BRCA-positive prostate cancer
Charlie Schmidt
Combining different biopsies limits uncertainty in prostate cancer diagnosis
Charlie Schmidt
New radiation therapies keep advanced prostate cancer in check
Charlie Schmidt
New study compares long-term side effects from different prostate cancer treatments
Charlie Schmidt
African American and white men who receive comparable treatments for prostate cancer have similar survival
Charlie Schmidt
Researchers urge prostate cancer screening for men with BRCA gene defects
Charlie Schmidt
Most men can hold off on radiation after prostate cancer surgery
Charlie Schmidt
Darolutamide approved for nonmetastatic castration-resistant prostate cancer
Men's Health
Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer
Charlie Schmidt
Popular drugs used for treating enlarged prostates associated with high-grade prostate cancer
Charlie Schmidt
From Brexit to TRexit: Transperineal biopsies pose a challenge to the traditional transrectal biopsy method
Charlie Schmidt
Can a man with abnormal PSA and a negative diagnostic MRI avoid a prostate biopsy? It’s debatable
Charlie Schmidt
Highly accurate test reveals recurring prostate cancer
Men's Health
African American men respond better to treatments for advanced prostate cancer in clinical trials
Charlie Schmidt
Diet and exercise limit heart disease risk in men undergoing hormonal treatments for advanced prostate cancer
Charlie Schmidt
Hormonal therapy for aggressive prostate cancer: How long is enough?
Charlie Schmidt
Long-term statin use protects against prostate cancer death
Charlie Schmidt
Smoking tied to more aggressive prostate cancer
Charlie Schmidt
Investigators unveil metastatic prostate cancer’s genomic landscape
Charlie Schmidt
A new option for immunotherapy in metastatic prostate cancer
Charlie Schmidt
Q&A with Dr. Daniel Rukstalis on prostatic urethral lift for enlarged prostates
Charlie Schmidt
New blood test may someday help guide the best treatment for aggressive prostate cancer
Men's Health
New blood test guides researchers toward the best treatment for aggressive prostate cancer
Men's Health
Influential task force issues new recommendations on prostate cancer screening
Recent Articles
Medicare versus Medicaid: Key differences
Lost a tooth? What to know about dental implants
Hyperbaric oxygen therapy: Evidence-based uses and unproven claims
Gatorade. Liquid IV. Do you need extra electrolytes?
Sexual violence can cast a long shadow on health
Prostate cancer: Short-course radiation just as effective as longer-term treatments
Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet
Can a quick snooze help with energy and focus? The science behind power naps
Autism: The challenges and opportunities of an adult diagnosis
Hospice care: Overview of a compassionate approach to end-of-life care
